| I. BL | II. 3 M | III. 6 M | IV. 9 M | V. 12 M | VI. 15 M | VII. 18 M | ANOVA |
Group A (n = 24) | 25.5 ± 3.3 | 26.5 ± 3.2 | 26.6 ± 3.1 | 26.6 ± 3.1 | 26.9 ± 3.2 | 26.8 ± 2.9 | 27.1 ± 2.7 | I < VII* |
Placebo A (n = 22) | 23.5 ± 3.6 | 23.7 ± 3.8 | 23.0 ± 3.7 | 24.0 ± 3.6 | 22.8 ± 3.6 | 22.4 ± 4.1 | 22.1 ± 4.1 | _ |
Group B (n = 32) | 26.3 ± 2.3 | 26.9 ± 2.1 | 27.4 ± 1.8 | 27.7 ± 2.0 | 27.6 ± 2.1 | 27.7 ± 1.9 | 28.0 ± 1.7 | I < IV* I < V* I < VI* I < VII* |
Placebo B (n = 20) | 23.8 ± 3.5 | 23.3 ± 3.7 | 22.7 ± 3.7 | 23.0 ± 3.3 | 22.0 ± 3.1 | 21.4 ± 3.7 | 20.3 ± 3.8 | I > VI* I > VII* |